St. Jude Children’s Research Hospital Names New Director and VP

Cancer Biology Program pic

St. Jude Children’s Research Hospital
Image: stjude.org

As the clinical pharmacist for an emergency department, Ashkan Khabazian, PharmD, is responsible for administering medication based on patients’ emergency needs at Sharp HealthCare in San Diego, California. Outside of work, Dr. Ashkan Khabazian donates to St. Jude Children’s Research Hospital.

St. Jude Children’s Research Hospital is known for being a research hospital dedicated to helping children who have cancer. This includes both treatment for patients, and researching new ways to help young people who are battling the disease. In December of 2016, St. Jude named Ellis J. Neufeld, MD, PhD, as the new clinical director and executive vice president of the hospital.

Dr. Neufeld joins St. Jude as an experienced professional skilled in pediatric hematology. He has held the Egan Family Foundation Chair in Transitional Medicine while a professor of pediatrics at Harvard Medical School, and was the associate chief at the Boston Children’s Cancer and Blood Disorders Center. Dr. Neufeld also has previous experience working as a physician and scientist within a laboratory setting. His new role will begin in March of 2017.

St. Jude Children’s Research Hospital’s Partners in Hope Program

Partners in Hope Program pic

Partners in Hope Program
Image: waystohelp.stjude.org

In his role as Emergency Department Clinical Pharmacist at Sharp Memorial Hospital in San Diego, Ashkan Khabazian, PharmD, works with physicians to select the proper medications for patients . Also involved in charitable giving, Dr. Ashkan Khabazian donates to St. Jude Children’s Research Hospital.

St. Jude Children’s Research Hospital offers numerous ways for contributors to get involved in its work with children. One such way is through the Partners in Hope program. By participating in the program, monthly donors can help alleviate the cost of health care for children with life-altering diseases. Donations help provide children access to leading-edge treatments, such as proton therapy, which is the safest and most powerful treatment for cancer in children.

By participating in the Partners in Hope program, donors contribute not only to treatment but also to research initiatives, such as the St. Jude Children’s Research Hospital-Washington University Pediatric Cancer Genome Project. Through this groundbreaking project, St. Jude’s has sequenced more than 700 types of cancer that affect children.